Notably, OV treatment elevates CD103+ DC levels in lymph nodes from 5% to 25% and increases the formation of DC–tumor synapses by 300%, thereby enabling efficient cross-presentation of tumor antigens and activation of cytotoxic T cells (14, 15). Here, ITGAE is linked to neoplasm.